We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Rapid Diagnostic Tests Evaluated for Human Plasmodium knowlesi

By LabMedica International staff writers
Posted on 27 Mar 2014
Rapid diagnostic tests (RDTs) have been evaluated for the diagnosis of Plasmodium knowlesi, a malaria parasite of Southeast Asian macaques, Macaca fascicularis that infects humans and can cause fatal malaria.

Until recently only four types of Plasmodium (P. falciparum, P. vivax, P. malariae, and P. ovale) were known to cause malaria in humans, however, a fifth species, P. knowlesi, has been identified as a cause of human malaria in almost all countries in Southeast Asia. P. knowlesi is difficult to diagnose by microscopy because of morphological similarity to P. malariae.

Scientists at the Universiti Malaysia Sarawak, (Malaysia) and their international colleagues diagnosed by microscopy 40 malaria patients, 28 P. knowlesi, 10 P. vivax, and 2 P. falciparum. Patient blood samples were used to determine parasitaemia by microscopy, confirm the Plasmodium species present by polymerase chain reaction (PCR) and evaluate three RDTs using frozen blood samples from 41 P. knowlesi malaria patients.

A large number of RDTs are available for malaria diagnosis, including the three used in this study: OptiMAL-IT (DiaMed; Mississauga, ON, Canada), BinaxNOW Malaria (Alere; Waltham, MA, USA), and Paramax-3 malaria Pf/Pv/Pan (Zephyr Biomedical Systems; Goa, India). The sensitivity of each RDT was calculated with nested PCR results as the reference standard.

OptiMAL-IT was the most sensitive RDT, with a sensitivity of 71% (20/28) for fresh and 73% (30/41) for frozen P. knowlesi samples. However, the test was not specific and P. knowlesi samples cross-reacted with the P. falciparum LDH test reagent in 18 of the 20 fresh samples identified. BinaxNOW Malaria correctly detected non-P. falciparum malaria in P. knowlesi samples but was the least sensitive, detecting only 29% (8/28) of fresh and 24% (10/41) of frozen samples. The Paramax-3 RDT tested positive for P. vivax with PCR-confirmed P. knowlesi samples with sensitivities of 40% (10/25) with fresh and 32% (13/41) with frozen samples. All RDTs correctly identified P. falciparum- and P. vivax-positive controls with parasitaemias above 2,000 parasites/μL blood.

The authors concluded that the sensitivity of detection of P. knowlesi by the three RDTs evaluated is low compared with microscopy. Cross-reactivity is common between P. knowlesi-infected blood and both the P. falciparum-detecting antibody used in the OptiMAL-IT test and the P. vivax-detecting antibody used in the Paramax-3 test. Since not all species of malaria warrant the same level of medical care, misidentification can result in mismanagement, especially when the potentially severe knowlesi malaria is misdiagnosed as vivax malaria. The study was published on February 18, 2014, in the Malaria Journal.

Related Links:

Universiti Malaysia Sarawak
DiaMed
Alere



Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Coagulation Analyzer
CS-2400
New
Respiratory QC Panel
Assayed Respiratory Control Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.